STEMGEN
Dead / Cancelled — Cancelled — Section 8 (as of 16 Jan 2010)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 74731515
- Registration number
- 2247917
- Mark type
- Word mark
- Filed
- 20 Sept 1995
- Published for opposition
- 04 Jun 1996
- Registered
- 25 May 1999
Goods and services
- Class 005 — Pharmaceuticals: prescription pharmaceutical for use in stimulating blood cell production
Owner
- BIOVITRUM AB (PUBL), STOCKHOLM, SE
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
- Amgen Inc., Thousand Oaks, CA, US
Prosecution history
- 16 Jan 2010 — CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
- 27 May 2009 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Jul 2007 — CASE FILE IN TICRS
- 16 Jan 2007 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 26 May 2006 — RESPONSE RECEIVED TO POST REG. ACTION - SEC. 8 & 15
- 30 May 2006 — PAPER RECEIVED
- 23 Mar 2006 — POST REGISTRATION ACTION MAILED - SEC. 8 & 15
- 23 Jan 2006 — ASSIGNED TO PARALEGAL
- 22 Nov 2005 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 22 Nov 2005 — TEAS SECTION 8 & 15 RECEIVED
- 25 May 1999 — REGISTERED-PRINCIPAL REGISTER
- 28 Mar 1999 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 16 Mar 1999 — ASSIGNED TO EXAMINER
- 08 Mar 1999 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Feb 1999 — USE AMENDMENT FILED